Phase II
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis
- Study IRB#:2000039264
- Last Updated:10/01/2026
Contact Us
For more information about this study, including how to volunteer, contact:
Nicole Olszewski
- Phone Number: 203-785-5505
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877-978-8343 for more information.
